High drug prices “infecting” generics: Experts

Haematologists in the US have accused the pharmaceutical industry of using strategies to delay patient access to cheaper generic drugs in a bid to maximise profits. Writing in Blood  forum article lead author Hagop Kantarjian, MD, of The University of Texas MD Anderson Cancer Center said pharmaceutical companies use a variety of strategies to delay, prevent, ...

Already a member?

Login to keep reading.

© 2021 the limbic